Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 19Phase 3 18Phase 1/2 13Phase NA 7Phase 2/3 4Phase EARLY_PHASE1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Glioblastoma 16Glioma 14Neoplasms 13Breast Neoplasms 13Prostatic Neoplasms 12Brain Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Multiple Myeloma 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Recurrence 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Skin Neoplasms 4Lymphoma 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Colonic Neoplasms 3Astrocytoma 3

Interventions

adavosertib 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fallopian Tube Neoplasms × 90 days × Clear all
NCT02659241 2026-04-15

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
38 enrolled
Gynecologic

Carcinoma, Fallopian Tube Neoplasms

NCT05080946 2026-04-01

Using Aspirin to Improve Immunological Features of Ovarian Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Recruiting
100 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡